一周基金業績:股基凈值上漲5.31%
上(shang)(shang)周(zhou)(zhou)A股市場震蕩(dang)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),上(shang)(shang)證綜指(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)3.54%,深證成指(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)5.43%,創業板指(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)6.38%。從申萬行(xing)業來看,上(shang)(shang)周(zhou)(zhou)休閑服務行(xing)業指(zhi)(zhi)數(shu)領(ling)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),電子、醫藥(yao)生物(wu)等(deng)行(xing)業指(zhi)(zhi)數(shu)小幅上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),銀行(xing)行(xing)業指(zhi)(zhi)數(shu)保(bao)持持平(ping)(ping)(ping),國防軍工行(xing)業指(zhi)(zhi)數(shu)相對小幅下跌(die)。在此背景(jing)下,股票型基金(jin)凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)周(zhou)(zhou)加(jia)權平(ping)(ping)(ping)均(jun)(jun)(jun)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)5.31%,納(na)入統計的(de)474只(zhi)(zhi)(zhi)(zhi)產(chan)品中有(you)470只(zhi)(zhi)(zhi)(zhi)產(chan)品凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),僅4只(zhi)(zhi)(zhi)(zhi)基金(jin)未能(neng)收漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)。指(zhi)(zhi)數(shu)型基金(jin)凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)周(zhou)(zhou)加(jia)權平(ping)(ping)(ping)均(jun)(jun)(jun)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)4.56%,納(na)入統計的(de)1158只(zhi)(zhi)(zhi)(zhi)產(chan)品中有(you)1124只(zhi)(zhi)(zhi)(zhi)產(chan)品凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),配(pei)置醫藥(yao)生物(wu)主題(ti)的(de)基金(jin)周(zhou)(zhou)內領(ling)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)。混合型基金(jin)凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)周(zhou)(zhou)加(jia)權平(ping)(ping)(ping)均(jun)(jun)(jun)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)4.03%,納(na)入統計的(de)3870只(zhi)(zhi)(zhi)(zhi)產(chan)品中有(you)3796只(zhi)(zhi)(zhi)(zhi)產(chan)品凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)。QDII基金(jin)凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)周(zhou)(zhou)加(jia)權平(ping)(ping)(ping)均(jun)(jun)(jun)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)0.76%,投資醫藥(yao)與科技的(de)QDII周(zhou)(zhou)內領(ling)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang),納(na)入統計的(de)291只(zhi)(zhi)(zhi)(zhi)產(chan)品中有(you)201只(zhi)(zhi)(zhi)(zhi)產(chan)品凈(jing)(jing)值(zhi)(zhi)上(shang)(shang)漲(zhang)(zhang)(zhang)(zhang)(zhang)(zhang)。
公開市場方面,上(shang)(shang)周(zhou)有1600億元(yuan)(yuan)逆回購到期,央(yang)行通過逆回購投(tou)放2800億元(yuan)(yuan),全口徑看,全周(zhou)凈(jing)投(tou)放資金1200億元(yuan)(yuan),資金面維持寬松態勢(shi),隔夜Shibor利(li)率(lv)周(zhou)內小幅波動(dong),繼(ji)續維持在較(jiao)低(di)水(shui)平(ping)。在此背景下(xia),債券型基金凈(jing)值上(shang)(shang)周(zhou)加權平(ping)均上(shang)(shang)漲0.07%,納入(ru)統計(ji)的3361只產品中有1698只產品凈(jing)值上(shang)(shang)漲。短(duan)期理財債基收益(yi)優于貨幣基金,最近7日平(ping)均年化收益(yi)率(lv)分別為1.82%、1.70%。
股票型(xing)基金(jin)(jin)方(fang)面,鵬華價(jia)值(zhi)精選以周凈(jing)(jing)值(zhi)上漲(zhang)11.29%居(ju)首。指數型(xing)基金(jin)(jin)方(fang)面,國泰中證生物醫藥ETF周內(nei)表(biao)現最佳(jia),周內(nei)凈(jing)(jing)值(zhi)上漲(zhang)12.23%。混合型(xing)基金(jin)(jin)方(fang)面,英大睿盛C周內(nei)凈(jing)(jing)值(zhi)上漲(zhang)15.21%,表(biao)現最佳(jia)。債(zhai)券(quan)型(xing)基金(jin)(jin)方(fang)面,中銀轉債(zhai)增強A周內(nei)以6.61%的漲(zhang)幅位(wei)(wei)居(ju)第(di)一。QDII基金(jin)(jin)中,易方(fang)達全球醫藥行(xing)業(ye)美(mei)元周內(nei)博(bo)取(qu)第(di)一位(wei)(wei),產品凈(jing)(jing)值(zhi)上漲(zhang)5.96%。